Associated Papers
SDHA-related phaeochromocytoma and paraganglioma: review and clinical management.
Kaplan AI et al.
Endocrine-related Cancer, 2024
39133175 (PubMed )
Supplement: supplementary_table_1-2.pdf
Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM et al.
Endocrine Oncology (bristol, England), 2023
37434649 (PubMed )
Supplement: supplementary_table_1.xlsx › Missense_Variants
SDH-deficient renal cell carcinoma: A case report associated with a novel germline mutation.
Milionis V et al.
Clinical Case Reports, 2021
Surveillance of succinate dehydrogenase gene mutation carriers: Insights from a nationwide cohort.
Martins RG et al.
Clinical Endocrinology, 2020
Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers.
Rijken JA et al.
Cancers, 2019
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis.
Papathomas TG et al.
European Journal of Endocrinology, 2014
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients.
Piccini V et al.
Endocrine-related Cancer, 2012
SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis.
Henderson A et al.
Familial Cancer, 2009
The occurrence of SDHB gene mutations in pheochromocytoma.
Van Nederveen FH et al.
Annals of the New York Academy of Sciences, 2006
Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F et al.
Jama, 2005
Select a paper to view details